CP-724,714

DRUG2 trials

Sponsors

Jonsson Comprehensive Cancer Center, Pfizer

Conditions

Breast CancerBreast NeoplasmsNeoplasm Metastasis

Phase 1

CP-724,714 in Treating Patients With Metastatic Breast Cancer

CompletedNCT00055926

Jonsson Comprehensive Cancer CenterBreast Cancer

Start: 2003-01-31End: 2005-05-31Updated: 2020-08-03

Phase 2

A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer

TerminatedNCT00102895

PfizerBreast Neoplasms, Neoplasm Metastasis

Start: 2005-04-30End: 2005-09-30Target: 25Updated: 2010-08-27